Infinity Pharmaceuticals, Inc. (INFI)
(Delayed Data from NSDQ)
$1.71 USD
+0.06 (3.64%)
Updated May 3, 2019 04:00 PM ET
After-Market: $1.72 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMEarnings News For INFI
-
Infinity: Q1 Earnings Snapshot
-
Infinity Pharmaceuticals (INFI) Reports Q4 Loss, Lags Revenue Estimates
-
Will Infinity Pharmaceuticals (INFI) Report Negative Q4 Earnings? What You Should Know
-
Infinity Pharmaceuticals (INFI) Reports Q3 Loss, Lags Revenue Estimates
-
Infinity: Q3 Earnings Snapshot
-
Infinity Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Business Update
-
Infinity Pharmaceuticals (INFI) Reports Q2 Loss, Tops Revenue Estimates
-
Infinity Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Business Update
-
Infinity Pharmaceuticals (INFI) Reports Q1 Loss, Tops Revenue Estimates
-
Infinity Pharmaceuticals (INFI) Reports Q4 Loss, Tops Revenue Estimates
-
Infinity Pharmaceuticals (INFI) Reports Q3 Loss, Misses Revenue Estimates
-
Infinity Pharmaceuticals (INFI) Reports Q2 Loss, Tops Revenue Estimates
-
Infinity Pharmaceuticals (INFI) May Report Negative Earnings: Know the Trend Ahead of Q2 Release
-
Infinity Pharmaceuticals (INFI) Reports Q1 Loss, Tops Revenue Estimates
-
Infinity Pharmaceuticals (INFI) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
-
Infinity Pharmaceuticals (INFI) Reports Q4 Loss, Tops Revenue Estimates
-
Infinity Pharmaceuticals (INFI) Reports Q3 Loss, Tops Revenue Estimates
-
Infinity Pharmaceuticals (INFI) May Report Negative Earnings: Know the Trend Ahead of Q3 Release
-
Infinity Pharmaceuticals (INFI) Reports Q2 Loss, Tops Revenue Estimates
-
Infinity (INFI) Up 4% Since Last Earnings Report: Can It Continue?
-
Infinity (INFI) Q1 Earnings Lag Estimates, IPI-549 in Focus
-
Infinity Pharmaceuticals (INFI) Reports Q1 Loss, Tops Revenue Estimates
-
Will Infinity Pharmaceuticals (INFI) Report Negative Q1 Earnings? What You Should Know
-
Infinity (INFI) Down 28.2% Since Last Earnings Report: Can It Rebound?
-
Infinity (INFI) Q4 Loss Wider Than Expected, IPI-549 in Focus